Generation and clinical applications of stem cells in regenerative medicines
Article Main
Abstract
Since the discovery of stem cells, they have been claimed to be nature’s miracle due to their unique properties, which set them apart from other cell types. It has fascinated the world with its myriad of opportunities in regenerative medicine, such as treating blood-borne cancers, neurodegenerative diseases and disorders, immune system diseases, heart diseases, etc. Although Stem Cell Therapy is yet to be commercialized in India, research and clinical trials using Hematopoietic Stem Cell Transplantation are being conducted to understand the efficacy of stem cells in the remission of various malignant and non-malignant diseases such as Thalassemia, Acute Lymphoblastic Leukemia, Sickle Cell Disease, Aplastic Anemia, Hodgkin’s Lymphoma and Juvenile Rheumatoid Arthritis among other diseases. Stem cell research has bloomed over the years and has demonstrated immense potential in Embryonic Stem Cell Therapy, Somatic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy and, with further understanding of stem cells, it could also be applied in drug modelling and drug development, skin replacement and regeneration, organ repair and regeneration and disease modelling for drug testing, revolutionizing the healthcare industry in the future. The present review discusses the research on stem cells, their applications in regenerative medicine, and economic, regulatory and ethical concerns.
Article Details
Article Details
Embryonic Stem Cells (ESCs), Hematopoietic Stem Cell Transplantation (HSCT), Induced Pluripotent Stem Cells (iPSCs), Regenerative Medicine, Somatic Stem Cells (SSCs)
Chattopadhyay, R. & Srivastav, R. (2024). Mechanisms and Applications of CRISPR mediated Gene Silencing. International Research Journal of Engineering and Technology (IRJET). https://www.irjet.net/archives/V11/i3/IRJET-V11I3186.pdf
Fellheimer, & Harrison,. (2024). Revolutionizing Orthopaedics: Exploring the Therapeutic Potential of Stem Cells. Bone Bulletin. Available at: https://jdc.jefferson.edu/bone_bulletin/vol2/iss1/6
Varzideh, F. Gambardella, J. Kansakar, U. Jankauskas, SS. & Santulli, G. (2023). Molecular Mechanisms Underlying Pluripotency and Self-Renewal of Embryonic Stem Cells. International Journal of Molecular Science, 24(9), 8386. doi: 10.3390/ijms24098386
de Morree, A. & Rando, TA. (2023). Regulation of adult stem cell quiescence and its functions in the maintenance of tissue integrity. Nature Reviews Molecular Cell Biology, 24(5):334-354. doi: 10.1038/s41580-022-00568-6
Aboul-Soud, MAM. Alzahrani, AJ. & Mahmoud, A. (2021). Induced Pluripotent Stem Cells (iPSCs)-Roles in Regenerative Therapies, Disease Modelling and Drug Screening. Cells, 10(9):2319. doi: 10.3390/cells10092319
Ramalho-Santos, M. & Willenbring, H. (2007). On the origin of the term "stem cell". Cell Stem Cell, 1(1):35-38. doi: 10.1016/j.stem.2007.05.013
Weissman, IL. & Shizuru, JA. (2008). The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases. Blood, 112(9):3543-53. doi: 10.1182/blood-2008-08-078220
Khan, FA. Almohazey, D. Alomari, M. & Almofty, SA. (2018). Isolation, Culture, and Functional Characterization of Human Embryonic Stem Cells: Current Trends and Challenges. Stem Cells Int, 2018:1429351. doi: 10.1155/2018/1429351
Zhu, Z. & Huangfu, D. (2013). Human pluripotent stem cells: an emerging model in developmental biology. Development, 140(4):705-17. doi: 10.1242/dev.086165
Ferreira, L. (2014). Stem Cells: A Brief History and Outlook. WordPress. Retrieved 3 December 2019
Takahashi, K. Tanabe, K. Ohnuki, M. Narita, M. Ichisaka, T. Tomoda, K. & Yamanaka, S. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131(5):861-72. doi: 10.1016/j.cell.2007.11.019
Boyle, & Rebecca (2021). Injured Brazilian Wolf Is First Wild Animal Treated With Stem Cells. Popular Science, January 15, 2011. Retrieved August 7, 2021, https://www.popsci.com/science/article/2011-01/injured-brazilian-wolf-first-wild-animal-treated-stem-cells/
Usui, J. Kobayashi, T. Yamaguchi, T. Knisely, AS. Nishinakamura, R. & Nakauchi, H. (2012). Generation of kidney from pluripotent stem cells via blastocyst complementation. Am J Pathol., 180(6):2417-26. doi: 10.1016/j.ajpath.2012.03.007
Pagliuca, FW. Millman, JR. Gürtler, M. Segel, M. Van Dervort, A. Ryu, JH. Peterson, QP. Greiner, D. & Melton, DA. (2014). Generation of functional human pancreatic β cells in vitro. Cell, 159(2):428-39. doi: 10.1016/j.cell.2014.09.040
Callaway, E. (2017). Reprogrammed cells relieve Parkinson's symptoms in trials. Nature. https://doi.org/10.1038/nature.2017.22531
Lee, JP. Zhang, R. Yan, M. Duggineni, S. Wakeman, DR. Niles, WL. Feng, Y. Chen, J. Hamblin, MH. Han, EB. Gonzalez, R. Fang, X. Zhu, Y. Wang, J. Xu, Y. Wenger, DA. Seyfried, TN., An, J. Sidman, RL. Huang, Z. & Snyder, EY. (2020). Chemical mutagenesis of a GPCR ligand: Detoxifying "inflammo-attraction" to direct therapeutic stem cell migration. Proc Natl Acad Sci U S A, 117(49):31177-31188. doi: 10.1073/pnas.1911444117
Zakrzewski, W. Dobrzyński, M. Szymonowicz, M. & Rybak, Z. (2019). Stem cells: past, present, and future. Stem Cell Research & Therapy, 10(1):68. doi: 10.1186/s13287-019-1165-5
Bieńko, Karolina. Monika, Leszcz. Marta, Więckowska. Justyna, Białek. Alicja, Petniak. Rafał, Szymanowski. Agnieszka, Wilińska. Bartosz, Piszcz. Arkadiusz, Krzyżanowski. Anna, Kwaśniewska. Bartosz, J. Płachno. Paulina, Gil-Kulik. & Janusz, Kocki. (2023). VEGF Expression in Umbilical Cord MSC Depends on the Patient’s Health, the Week of Pregnancy in Which the Delivery Took Place, and the Body Weight of the Newborn – Preliminary Report. Stem Cells and Cloning: Advances and Applications 16, pages 5-18. https://www.tandfonline.com/doi/full/10.2147/SCC AA .S3 99303
Kolios, G. & Moodley, Y. (2013). Introduction to stem cells and regenerative medicine. Respiration, 85(1):3-10. doi: 10.1159/000345615
Aly, RM. (2020). Current state of stem cell-based therapies: an overview. Stem Cell Investigation, 7:8. doi: 10.21037/sci-2020-001
Teshigawara, R. Cho, J. Kameda, M. et al.. (2017). Mechanism of human somatic reprogramming to iPS cell. Laboratory Investigation, 1152–1157. https://doi.org/10.1038/labinvest.2017.56
Baghai, Naini. F. Aminishakib, P. Abdollahi, A. Hodjat, M. Mohammadpour, H. & Kardouni, Khoozestani, N. (2019). Relative Expression of OCT4, SOX2 and NANOG in Oral Squamous Cell Carcinoma Versus Adjacent Non- Tumor Tissue. Asian Pacific Journal of Cancer Prevention, 20(6):1649-1654. doi: 10.31557/APJCP.2019.20.6.1649
Aguirre, M. Escobar, M. Forero, Amézquita, S. Cubillos, D. Rincón, C. Vanegas, P. Tarazona, MP. Atuesta, Escobar. S. Blanco, JC. & Celis, LG. (2023). Application of the Yamanaka Transcription Factors Oct4, Sox2, Klf4, and c-Myc from the Laboratory to the Clinic. Genes (Basel), 14(9):1697. doi: 10.3390/genes14091697
Indian Council of Medical Research (2017). National Guidelines for Stem Cell Research. (2017). Available from: https://main.icmr.nic.in/sites/default/files/guidelines/Guidelines_for_stem_cell_research_2017.pdf
Lucarelli, G. Isgrò, A. Sodani, P. & Gaziev, J. (2012). Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia. Cold Spring Harb Perspect Med, 2(5):a011825. doi: 10.1101/cshperspect.a011825
Huang, C. Qu, Y. Liu, S. Nie, S. & Jiang, H. (2021). Hematopoietic stem cell transplantation for thalassemia major using HLA fully-matched and mismatched donor grafts. Translational Pediatrics, 10(6):1552-1565. doi: 10.21037/tp-20-415
Bondarenko, Sergey. N. Moiseev, Ivan S. Slesarchuk, Olga. A. Darskaya, Elena. I. Ekushev, Kirill. A. Smirnova, Anna. G. Alyanskiy, Alexander. L. Gindina, Tatyana. L. Babenko, Elena. V. Kuzmich, Elena. V. Semenova, Elena. V. Kulagin, Alexander. D. Zubarovskaya, Luydmila. S. & Afanasyev, Boris. V. (2016). Allogeneic hematopoietic stem cell transplantation in children and adults with acute lymphoblastic leukemia. Cellular Therapy and Transplantation, 5 (2 (15)), 12-20. http://cttjournal.com/en/archive/vypusk-5-nomer-2/regulyarnye-stati/allogennaya-transplantatsiya-gemopoeticheskikh-stvolovykh-kletok-u-detey-i-vzroslykh-s-ostrym-limfob/
Saraf, SL. Oh, AL. Patel, PR. Jalundhwala, Y. Sweiss, K. Koshy, M. Campbell-Lee, S. Gowhari, M. Hassan, J. Peace, D. Quigley, JG. Khan, I. Molokie, RE. Hsu, LL. Mahmud, N. Levinson, DJ. Pickard, AS. Garcia, JG. Gordeuk, VR. & Rondelli, D. (2016). Nonmyeloablative Stem Cell Transplantation with Alemtuzumab/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell Disease. Biol Blood Marrow Transplant, 22(3):441-8. doi: 10.1016/j.bbmt.2015.08.036
Wilfred, G. Ong, TC. Sh, Shahnaz. SAK. Wah, HK. Carlo, ES. Jameela, S. & Mui, Tan. S. (2022). Allogeneic Hematopoietic Stem Cell Transplantation in Severe Aplastic Anemia: A Single Centre Experience in Malaysia. Blood Cell Ther., 5(2):45-53. doi: 10.31547/bct-2021-018
Kadkhoda, D. Nikoonezhad, M. Baghestani, AR. Parkhideh, S. Momeni-Varposhti, Z. & Khadem, Maboudi. AA. (2023). Prognostic Factors for the Long-Term Survival after Hematopoietic Stem Cell Transplantation in Patients with Hodgkin Lymphoma. Asian Pacific Journal for Cancer Prevention, 24(2):417-423. doi: 10.31557/APJCP.2023.24.2.417
M F Silva, J. Ladomenou, F. Carpenter, B. Chandra, S. Sedlacek, P. Formankova, R. Grandage, V. Friswell, M. Cant, AJ. Nademi, Z. Slatter, MA. Gennery, AR. Hambleton, S. Flood, TJ. Lucchini, G. Chiesa, R. Rao, K. Amrolia, PJ. Brogan, P. Wedderburn, LR. Glanville, JM. Hough, R. Marsh, R. Abinun, M. & Veys, P. (2018). Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis. Blood Advances, 2(7):777-786. doi: 10.1182/bloodadvances.2017 014449
Morelle, G. Castelle, M. Pinto, G. et al.. (2021). Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis. Pediatr Rheumatol. https://doi.org/10.1186/s12969-021-00523-3
Pawlowska, AB. Sun, V. Calvert, GT. Karras, NA. Sato, JK. Anderson, CP. Cheng, JC. DiMundo, JF. Femino, JD. Lu, J. Yang, D. Dagis, A. Miser, JS. & Rosenthal, J. (2021). Long-Term Follow-up of High-Dose Chemotherapy with Autologous Stem Cell Transplantation in Children and Young Adults with Metastatic or Relapsed Ewing Sarcoma: A Single-Institution Experience. Transplant Cell Ther, 27(1):72.e1-72.e7. doi: 10.1016/j.bbmt.2020.09.029
Van Laar, JM. Farge, D. Sont, JK. Naraghi, K. Marjanovic, Z. Larghero, J. Schuerwegh, AJ. Marijt, EW. Vonk, MC. Schattenberg, AV. Matucci-Cerinic, M. Voskuyl, AE. van de Loosdrecht, AA. Daikeler, T. Kötter, I. Schmalzing, M. Martin, T. Lioure, B. Weiner, SM. Kreuter, A. Deligny, C. Durand, JM. Emery, P. Machold, KP. Sarrot-Reynauld, F. Warnatz, K. Adoue, DF. Constans, J. Tony, HP. Del Papa, N. Fassas, A. Himsel, A. Launay, D. Lo Monaco, A. Philippe, P. Quéré, I. Rich, É. Westhovens, R. Griffiths, B. Saccardi, R. van den Hoogen, FH. Fibbe, WE. Socié, G. Gratwohl, A. & Tyndall, A. (2014). EBMT/EULAR Scleroderma Study Group. Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial. JAMA, 311(24):2490-8. doi: 10.1001/jama.2014.6368
Hallek, M. & Al-Sawaf, O. (2021). Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures. American Journal of Hematology, 96(12): 1679-1705. doi:10.1002/ajh.26367
Oscar, B. Lahoud, Sean, M. Devlin. Molly, A. Maloy. Lindsey, E. Roeker. Parastoo, B. Dahi. Doris, M. Ponce. Boglarka, Gyurkocza. Guenther, Koehne. James, W. Young. Hugo, R. Castro-Malaspina. Juliet, N. Barker. Esperanza, B. Papadopoulos. Ann, A. Jakubowski. Andrew, D. Zelenetz. Anthony, R. Mato. Sergio, A. Giralt. Miguel, A. Perales. & Craig, S. Sauter. (2021). Reduced-intensity conditioning hematopoietic stem cell transplantation for chronic lymphocytic leukemia and Richter’s transformation. Blood Advances, 5 (14): 2879–2889. doi: https://doi.org/10.1182/bloodadvances.2 020003726
Jo, H. Brito, S. Kwak, BM. Park, S. Lee, M-G. & Bin, B-H. (2021). Applications of Mesenchymal Stem Cells in Skin Regeneration and Rejuvenation. International Journal of Molecular Sciences, 22(5):2410. https://doi.org/10.3390/ijms22052410
Cable, J. Fuchs, E. Weissman, I. Jasper, H. Glass, D. Rando, TA. Blau, H. Debnath, S. Oliva, A. Park, S. Passegué, E. Kim, C. & Krasnow, MA. Adult stem cells and regenerative medicine-a symposium report. Ann N Y Acad Sci, 1462(1):27-36. doi: 10.1111/nyas.14243
Okano, H. & Morimoto, S. (2022). iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders. Cell Stem Cell, 29(2):189-208. doi: 10.1016/j.stem.2022.01.007
Turhan, AG. Hwang, JW. Chaker, D. Tasteyre, A. Latsis, T. Griscelli, F. Desterke, C. & Bennaceur-Griscelli, A. (2021). iPSC-Derived Organoids as Therapeutic Models in Regenerative Medicine and Oncology. Front Med (Lausanne), 8:728543. doi: 10.3389/fmed.2021.728543
Volarevic, V. Markovic, B.S. Gazdic, M. Volarevic, A. Jovicic, N. Arsenijevic, N. Armstrong, L. Djonov, V. Lako, M. Stojkovic, M. (2018). Ethical and Safety Issues of Stem Cell-Based Therapy. International Journal of Medical Sciences, 15(1), 36-45. https://doi.org/10.7150/ijms.21666.
Cianciosi, D. Ansary, J. Forbes-Hernandez, TY. Regolo, L. Quinzi, D. Gracia Villar, S. Garcia Villena, E. Tutusaus Pifarre, K. Alvarez-Suarez, JM. & Battino, M. et al..(2021). The Molecular Basis of Different Approaches for the Study of Cancer Stem Cells and the Advantages and Disadvantages of a Three-Dimensional Culture. Molecules, 26(9):2615. https://doi.org/10.3390/molecules26092615
Leventhal, A. Chen, G. Negro, A. & Boehm, M. (2012). The benefits and risks of stem cell technology. Oral Dis, 18(3):217-22. doi: 10.1111/j.1601-0825.2011.01870
Park, S.J. Kim, Y.Y. Han, J.Y. et al. (2024). Advancements in Human Embryonic Stem Cell Research: Clinical Applications and Ethical Issues. Tissue Engineering and Regenerative Medicine 21, 379–394 . https://doi.org/10.1007/s13770-024-00627-3
Ford, E. Pearlman, J. Ruan, T. Manion, J. Waller, M. Neely, G.G. & Caron, L. (2020). Human Pluripotent Stem Cells-Based Therapies for Neurodegenerative Diseases: Current Status and Challenges. Cells, 9(11):2517. https://doi.org/10.3390/cells9112517
Vatsa, P. et al.. (2022). Stem Cell Safety and Sterility Testing: A Promising Approach in Regenerative Medicine. https://doi.org/10.1007/978-981-16-7589-8_9
Insurance Regulatory and Development Authority of India (IRDAI). Guidelines on standardization of exclusions in health insurance contracts. Retrieved September 27, 2019. Available from: https://irdai.gov.in/hi/document-detail?documentId=392498

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This work is licensed under Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) © Author (s)